HCA Healthcare, Inc.: Form 10-Q for the period ended Jun 30, 2017
Filed with the SEC on Aug 4, 2017 and accepted by EDGAR at Aug 4, 2017, 16:35 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2017-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Interest expense | 3 months2017-04-01 to 2017-06-30 | $411.0m | us-gaap:InterestExpense |
| Interest expense | 6 months2017-01-01 to 2017-06-30 | $830.0m | us-gaap:InterestExpense |
| Income tax | 3 months2017-04-01 to 2017-06-30 | $365.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2017-01-01 to 2017-06-30 | $654.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2017-04-01 to 2017-06-30 | $657.0m | us-gaap:NetIncomeLoss |
| Net income | 6 months2017-01-01 to 2017-06-30 | $1.32bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2017-04-01 to 2017-06-30 | $1.75 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2017-01-01 to 2017-06-30 | $3.48 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2017-04-01 to 2017-06-30 | $1.79 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2017-01-01 to 2017-06-30 | $3.58 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2017-04-01 to 2017-06-30 | 375,338,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2017-01-01 to 2017-06-30 | 377,647,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Capital expenditure | 6 months2017-01-01 to 2017-06-30 | $1.30bn | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 6 months2017-01-01 to 2017-06-30 | $966.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2017-06-30 | $705.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2017-06-30 | $9.34bn | us-gaap:AssetsCurrent |
| Total assets | At period end2017-06-30 | $34.57bn | us-gaap:Assets |
| Current liabilities | At period end2017-06-30 | $5.77bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2017-06-30 | $39.65bn | us-gaap:Liabilities |
| Long-term debt | At period end2017-06-30 | $31.45bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2017-06-30 | $213.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2017-06-30 | −$6.79bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001193125-17-248794. Last ingested by Listed: Nov 11, 2026, 03:15 ET. Listed shows no prices and gives no investment advice.